SCHEMBL24188491

SCHEMBL24188491

Cn1c(C(C)(C)C)cc2c3ccccc3ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 5/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ CYP2A6 P11509 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ CYP1B1 Q16678 1/20 0.41
▸ GPR3 P46089 1/20 0.41
▸ MAPK14 Q16539 1/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ HPGD P15428 2/20 0.40
▸ HTT P42858 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ PHGDH O43175 1/20 0.39
▸ HPRT1 P00492 1/20 0.39
▸ RAB9A P51151 1/20 0.38
▸ CASP1 P29466 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10139087 0.76 KMT2A (0.50) ALDH1A1KMT2AKDM4EMAPTMEN1
SCHEMBL30435050 0.76 KMT2A (0.50) ALDH1A1KMT2AKDM4EMAPTMEN1
SCHEMBL25523182 0.74 PGR (0.43) HSD17B10ALDH1A1GPR3KMT2AKDM4E
SCHEMBL25523193 0.74 PGR (0.43) HSD17B10ALDH1A1GPR3KMT2AKDM4E
SCHEMBL12724782 0.74 HPGD (0.56) HSD17B10ALDH1A1TDP1HIF1AGPR3
SCHEMBL24188628 0.74 GPR3 (0.52) HSD17B10ALDH1A1TDP1GPR3KMT2A
SCHEMBL24188494 0.73 KDM4E (0.42) HSD17B10ALDH1A1TSHRGPR3MAPK14
SCHEMBL17551795 0.72 KMT2A (0.61) HSD17B10ALDH1A1CYP2A6TSHRTDP1
SCHEMBL17775123 0.71 ALKBH5 (0.46) ALDH1A1CYP2A6TDP1GPR3KMT2A
SCHEMBL24188493 0.70 GPR3 (0.52) HSD17B10ALDH1A1TDP1GPR3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220013735-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2022-01-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220013735-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OXA1L, ICOSLG, ODC1 HSD17B10 1781/4885ALDH1A1 174/4885CYP2A6 3124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback